Pillai Mamatha M, Elakkiya V, Gopinathan J, Sabarinath C, Shanthakumari S, Sahanand K Santosh, Dinakar Rai B K, Bhattacharyya Amitava, Selvakumar R
Tissue Engineering Laboratory, PSG Institute of Advanced Studies, Coimbatore, 641004, India.
Department of Biotechnology, PSG College of Technology, Coimbatore, 641004, India.
Cytotechnology. 2016 Oct;68(5):1747-61. doi: 10.1007/s10616-015-9926-1. Epub 2015 Oct 28.
The present study investigates the impact of biomolecules (biotin, glucose, chondroitin sulphate, proline) as supplement, (individual and in combination) on primary human meniscus cell proliferation. Primary human meniscus cells isolated from patients undergoing meniscectomy were maintained in Dulbecco's Modified Eagle's Medium (DMEM). The isolated cells were treated with above mentioned biomolecules as individual (0-100 µg/ml) and in combinations, as a supplement to DMEM. Based on the individual biomolecule study, a unique combination of biomolecules (UCM) was finalized using one way ANOVA analysis. With the addition of UCM as supplement to DMEM, meniscal cells reached 100 % confluency within 4 days in 60 mm culture plate; whereas the cells in medium devoid of UCM, required 36 days for reaching confluency. The impact of UCM on cell viability, doubling time, histology, gene expression, biomarkers expression, extra cellular matrix synthesis, meniscus cell proliferation with respect to passages and donor's age were investigated. The gene expression studies for E-cadherin and peroxisome proliferator-activated receptor (PPAR∆) using RT-qPCR and immunohistochemical analysis for Ki67, CD34 and Vimentin confirmed that UCM has significant impact on cell proliferation. The extracellular collagen and glycosaminoglycan secretion in cells supplemented with UCM were found to increase by 31 and 37 fold respectively, when compared to control on the 4th day. The cell doubling time was reduced significantly when supplemented with UCM. The addition of UCM showed positive influence on different passages and age groups. Hence, this optimized UCM can be used as an effective supplement for meniscal tissue engineering.
本研究调查了生物分子(生物素、葡萄糖、硫酸软骨素、脯氨酸)作为补充剂(单独及联合使用)对原代人半月板细胞增殖的影响。从接受半月板切除术的患者中分离出的原代人半月板细胞在杜氏改良 Eagle 培养基(DMEM)中培养。将分离出的细胞用上述生物分子单独(0 - 100 μg/ml)及联合作为 DMEM 的补充剂进行处理。基于单个生物分子的研究,通过单因素方差分析确定了一种独特的生物分子组合(UCM)。在 DMEM 中添加 UCM 作为补充剂后,半月板细胞在 60 mm 培养板中于 4 天内达到 100%汇合;而在不含 UCM 的培养基中的细胞达到汇合需要 36 天。研究了 UCM 对细胞活力、倍增时间、组织学、基因表达、生物标志物表达、细胞外基质合成、不同传代次数及供体年龄的半月板细胞增殖的影响。使用 RT-qPCR 对 E-钙黏蛋白和过氧化物酶体增殖物激活受体(PPAR∆)进行基因表达研究,以及对 Ki67、CD34 和波形蛋白进行免疫组织化学分析,证实 UCM 对细胞增殖有显著影响。与第 4 天的对照组相比,添加 UCM 的细胞中细胞外胶原蛋白和糖胺聚糖的分泌分别增加了 31 倍和 37 倍。添加 UCM 后细胞倍增时间显著缩短。UCM 的添加对不同传代次数和年龄组均显示出积极影响。因此,这种优化的 UCM 可作为半月板组织工程的有效补充剂。